1. Home
  2. IHD vs AVTX Comparison

IHD vs AVTX Comparison

Compare IHD & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IHD
  • AVTX
  • Stock Information
  • Founded
  • IHD 2011
  • AVTX 2011
  • Country
  • IHD United States
  • AVTX United States
  • Employees
  • IHD N/A
  • AVTX N/A
  • Industry
  • IHD Investment Managers
  • AVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IHD Finance
  • AVTX Health Care
  • Exchange
  • IHD Nasdaq
  • AVTX Nasdaq
  • Market Cap
  • IHD 89.7M
  • AVTX 88.4M
  • IPO Year
  • IHD N/A
  • AVTX 2015
  • Fundamental
  • Price
  • IHD $5.20
  • AVTX $8.18
  • Analyst Decision
  • IHD
  • AVTX Strong Buy
  • Analyst Count
  • IHD 0
  • AVTX 4
  • Target Price
  • IHD N/A
  • AVTX $33.00
  • AVG Volume (30 Days)
  • IHD 27.7K
  • AVTX 65.8K
  • Earning Date
  • IHD 01-01-0001
  • AVTX 03-28-2025
  • Dividend Yield
  • IHD 10.32%
  • AVTX N/A
  • EPS Growth
  • IHD N/A
  • AVTX N/A
  • EPS
  • IHD N/A
  • AVTX N/A
  • Revenue
  • IHD N/A
  • AVTX $820,000.00
  • Revenue This Year
  • IHD N/A
  • AVTX N/A
  • Revenue Next Year
  • IHD N/A
  • AVTX N/A
  • P/E Ratio
  • IHD N/A
  • AVTX N/A
  • Revenue Growth
  • IHD N/A
  • AVTX N/A
  • 52 Week Low
  • IHD $4.49
  • AVTX $4.17
  • 52 Week High
  • IHD $5.47
  • AVTX $34.46
  • Technical
  • Relative Strength Index (RSI)
  • IHD 55.82
  • AVTX 52.50
  • Support Level
  • IHD $5.11
  • AVTX $7.82
  • Resistance Level
  • IHD $5.25
  • AVTX $8.50
  • Average True Range (ATR)
  • IHD 0.06
  • AVTX 0.78
  • MACD
  • IHD 0.01
  • AVTX 0.20
  • Stochastic Oscillator
  • IHD 73.68
  • AVTX 73.11

About IHD Voya Emerging Markets High Income Dividend Equity Fund

Voya Emerging Markets High Dividend Equity Fund is a diversified closed-end management investment company. Its primary investment objective is to provide total return through a combination of current income, capital gains, and capital appreciation. The company seeks to achieve its investment objectives by investing principally in a portfolio of equity securities, and issuers in emerging market countries. The Fund will also normally seek to secure gains and enhance the stability of returns over a market cycle by writing (selling) call options on selected exchange-traded funds (ETFs) and/or international, regional, or country indices of equity securities, and/or on equity securities.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

Share on Social Networks: